⌘K

Login Start Free

Home/Filings/4/0001628280-25-016486

4//SEC Filing

Bumcrot David 4

Accession 0001628280-25-016486

CIK 0001736730other

View on SEC.gov Company Profile

Filed

Apr 2, 8:00 PM ET

Accepted

Apr 3, 4:09 PM ET

Size

5.5 KB

Accession

0001628280-25-016486

Insider Transaction Report

Form 4

Period: 2025-04-01

Camp4 Therapeutics CorpCAMP

Chief Scientific Officer

Transactions

Award
Stock Option (Right to Buy)
2025-04-01+45,000→ 45,000 total
Exercise: $3.86Exp: 2035-03-31→ Common Stock (45,000 underlying)

Footnotes (1)

[F1]The shares underlying the option vest in equal monthly installments over a period of four years commencing from the date of grant.

Documents

1 file

4
wk-form4_1743710973.xmlPrimary
FORM 4

Issuer

Camp4 Therapeutics Corp

CIK 0001736730

Entity typeother

Related Parties

1

filerCIK 0002033326

Filing Metadata

Form type: 4
Filed: Apr 2, 8:00 PM ET
Accepted: Apr 3, 4:09 PM ET
Size: 5.5 KB

View on SEC.gov